A new parliamentary report, ‘The New Frontier: Delivering better health for all Australians’, is recommending significant reforms to the health care system to ensure Australians have better and faster access to the wave of new medicines and technologies.
ITP Australia delivers a number of recommendations to improve treatment access for patients living with Immune Thrombocytopenia.
Delivered in February 2020, the National Strategic Action Plan is the first national and coordinated plan to help deliver better outcomes for more than the estimated 2 million Australians living with a rare disease.
ITP Australia partners with Rare Voices Australia to ensure that patients living with Immune Thrombocytopenia are part of the conversation.